EU medicines regulator backs Biogen’s ALS drug

The European medicines regulator on Friday recommended granting Biogen’s registration certificate to a drug for the deadly and progressive neurodegenerative disease known as amyotrophic lateral sclerosis. 

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM